231 related articles for article (PubMed ID: 9441713)
1. EPA's neurotoxicity risk assessment guidelines.
Boyes WK; Dourson ML; Patterson J; Tilson HA; Sette WF; MacPhail RC; Li AA; O'Donoghue JL
Fundam Appl Toxicol; 1997 Dec; 40(2):175-84. PubMed ID: 9441713
[TBL] [Abstract][Full Text] [Related]
2. The U.S. Environmental Protection Agency's risk assessment guidelines.
Jarabek AM; Farland WH
Toxicol Ind Health; 1990 Oct; 6(5):199-216. PubMed ID: 2274984
[TBL] [Abstract][Full Text] [Related]
3. Evolution and current status of neurotoxicity risk assessment.
Tilson HA
Drug Metab Rev; 1996; 28(1-2):121-39. PubMed ID: 8744593
[TBL] [Abstract][Full Text] [Related]
4. Risk management frameworks for human health and environmental risks.
Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
[TBL] [Abstract][Full Text] [Related]
5. Neurotoxicology risk assessment guidelines: developmental neurotoxicology.
Tilson HA
Neurotoxicology; 2000; 21(1-2):189-94. PubMed ID: 10794399
[TBL] [Abstract][Full Text] [Related]
6. Implementation of EPA Revised Cancer Assessment Guidelines: Incorporation of Mechanistic and Pharmacokinetic Data.
Page NP; Singh DV; Farland W; Goodman JI; Conolly RB; Andersen ME; Clewell HJ; Frederick CB; Yamasaki H; Lucier G
Fundam Appl Toxicol; 1997 May; 37(1):16-36. PubMed ID: 9193920
[TBL] [Abstract][Full Text] [Related]
7. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the U.S. Environmental Protection Agency methods for identification of hazards to developing organisms, Part II: The developmental toxicity testing guideline.
Claudio L; Bearer CF; Wallinga D
Am J Ind Med; 1999 Jun; 35(6):554-63. PubMed ID: 10332508
[TBL] [Abstract][Full Text] [Related]
9. The evolution of EPA's Exposure Factors Handbook and its future as an exposure assessment resource.
Phillips L; Moya J
J Expo Sci Environ Epidemiol; 2013; 23(1):13-21. PubMed ID: 22805985
[TBL] [Abstract][Full Text] [Related]
10. An analysis of the U.S. Environmental Protection Agency neurotoxicity testing guidelines.
Claudio L
Regul Toxicol Pharmacol; 1992 Oct; 16(2):202-12. PubMed ID: 1438999
[TBL] [Abstract][Full Text] [Related]
11. Developmental toxicity risk assessment: consensus building, hypothesis formulation, and focused research.
Kimmel CA
Drug Metab Rev; 1996; 28(1-2):85-103. PubMed ID: 8744591
[TBL] [Abstract][Full Text] [Related]
12. Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity: summary and implications.
Francis EZ; Kimmel CA; Rees DC
Neurotoxicol Teratol; 1990; 12(3):285-92. PubMed ID: 2196427
[TBL] [Abstract][Full Text] [Related]
13. FIFRA Subdivision F testing Guidelines: are these tests adequate to detect potential hormonal activity for crop protection chemicals? Federal Insecticide, Fungicide, and Rodenticide Act.
Stevens JT; Tobia A; Lamb JC; Tellone C; O'Neal F
J Toxicol Environ Health; 1997 Apr; 50(5):415-31. PubMed ID: 9140462
[TBL] [Abstract][Full Text] [Related]
14. Framework for metals risk assessment.
Fairbrother A; Wenstel R; Sappington K; Wood W
Ecotoxicol Environ Saf; 2007 Oct; 68(2):145-227. PubMed ID: 17889701
[TBL] [Abstract][Full Text] [Related]
15. The NAS perchlorate review: questions remain about the perchlorate RfD.
Ginsberg G; Rice D
Environ Health Perspect; 2005 Sep; 113(9):1117-9. PubMed ID: 16140613
[TBL] [Abstract][Full Text] [Related]
16. U.S. Environmental Protection Agency procedures and policies to estimate risk of injury to the male reproductive system.
Francis EZ
Prog Clin Biol Res; 1989; 302():3-16; discussion 17-20. PubMed ID: 2755956
[TBL] [Abstract][Full Text] [Related]
17. A proposed framework for assessing risk from less-than-lifetime exposures to carcinogens.
Felter SP; Conolly RB; Bercu JP; Bolger PM; Boobis AR; Bos PM; Carthew P; Doerrer NG; Goodman JI; Harrouk WA; Kirkland DJ; Lau SS; Llewellyn GC; Preston RJ; Schoeny R; Schnatter AR; Tritscher A; van Velsen F; Williams GM
Crit Rev Toxicol; 2011 Jul; 41(6):507-44. PubMed ID: 21591905
[TBL] [Abstract][Full Text] [Related]
18. US EPA's IRIS pilot program: establishing IRIS as a centralized, peer-reviewed data base with agency consensus. Integrated Risk Information System.
Mills A; Foureman GL
Toxicology; 1998 May; 127(1-3):85-95. PubMed ID: 9699796
[TBL] [Abstract][Full Text] [Related]
19. Approaches to cancer assessment in EPA's Integrated Risk Information System.
Gehlhaus MW; Gift JS; Hogan KA; Kopylev L; Schlosser PM; Kadry AR
Toxicol Appl Pharmacol; 2011 Jul; 254(2):170-80. PubMed ID: 21034767
[TBL] [Abstract][Full Text] [Related]
20. Uncertainties for endocrine disrupters: our view on progress.
Daston GP; Cook JC; Kavlock RJ
Toxicol Sci; 2003 Aug; 74(2):245-52. PubMed ID: 12730617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
